New Release of Cenduit’s IRT Platform and Quantum Interactive Updates Enable Efficient Technology Transfer and Increased Reports Customization for Clinical Trials
APRIL 23 – Durham, NC – Cenduit LLC continues to drive innovation and quality as a leader in the Interactive Response Technology (IRT) marketplace, with the latest release of the Cenduit IRT platform and Quantum Interactive ™.
Cenduit CIRT combines faster study set-up times with the flexibility and benefits of customization. This enables sponsors to better meet the complexities of today’s clinical trials. Quantum Interactive™ is a configurable study design platform that expedites time to Go Live and improves study quality.
Key features of the new release include the ability to better support central pharmacies and associated sites; provide better search capability for blocking kits that may have quality issues, the ability to scan kit barcodes to confirm dispensation transactions, and several new enhancements to the Quantum Interactive™ agile design platform.
Cenduit’s Director of Product Management Kim Lanza-Russo explained, “In today’s increasingly complex clinical research environment, sites rely on Cenduit to deliver an innovative, agile approach in Randomization and Trial Supply Management [RTSM] to meet patient outcomes. As always, with this new release, we asked users about their challenges, and continue to create quality enhancements that improve scalability and deliver quantifiable value in the study build process.”
Quantum Interactive™ enhancements included in this release further enable the ability to support customizations that are critical for meeting the needs of complex studies. The enhancements include:
· Capturing customization as part of the study specifications within Quantum Interactive™; this includes re-supply customization; report customization; data transfer; and tasks and alerts.
· Incorporating the creation of study reports within the initial study build phase; ensuring reports are made instantly available.
A technology-based innovation unlike any other in the market, Quantum Interactive™ creates a high-quality functioning prototype of the initial study build. The platform provides a user-friendly interface to guide the study build process for faster requirements discovery and is highly configurable, meeting the needs of any study design.
Kim Lanza-Russo added, “Cenduit continues its commitment to innovation, with an enterprise perspective based on years of experience, built with quality in mind. We continue increasing the scalability and power of our platform to meet and anticipate our users’ needs, no matter how complex.”
About Cenduit LLC
Cenduit enables clinical trial sponsors and CROs to safely, quickly and economically deliver new drugs and therapies to help save and improve lives. As the world leader in IRT systems, Cenduit offers customers consistently innovated rapid study startup software, clinical supply chain intelligence, clinical operations expertise and customer-centric CORE teams. With 500+ experts throughout the US, Europe and Asia, Cenduit helps customers manage clinical trials in over 100 countries, interacting with more than 600,000 patients at over 32,000 sites. Learn how Cenduit's experts can ensure your study needs are met on time and within budget. Visit www.cenduit.com for more information.
Contact:
Shannon L. Davies, Shannon.lappindavies@cenduit.com, +1 919-998-3393
Brenda Nashawaty, brenda@nashawaty.com, +1 617-688-3253
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
